Gelex

Commission Implementing Regulation (EU) 2018/524 of 28 March 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, clodinafop, clopyralid, cyprodinil, dichlorprop-P, fosetyl, mepanipyrim, metconazole, metrafenone, pirimicarb, Pseudomonas chlororaphis strain: MA 342, pyrimethanil, quinoxyfen, rimsulfuron, spinosad, thiacloprid, thiamethoxam, thiram, tolclofos-methyl, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)

In forceVersion 2018-03-28from 2018-04-07
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/regulation/2018/524@2018-03-28/en

Contents
  1. Preamble
    1. Article 1
    2. Article 2
  3. ANNEX
  4. ANNEX

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first paragraph of Article 17 thereof,

Whereas:

(1) Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.

(2) The approval periods of the active substances mepanipyrim, Pseudomonas chlororaphis Strain: MA 342, quinoxyfen, thiacloprid, thiram and ziram were last extended by Commission Implementing Regulation (EU) 2016/2016. The approval periods of those substances will expire on 30 April 2018.

(3) The approval periods of the active substances Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, clodinafop, metrafenone, pirimicarb, rimsulfuron, spinosad, thiamethoxam, tolclofos-methyl and triticonazole were extended by Commission Implementing Regulation (EU) No 487/2014. The approval periods of those substances will expire on 30 April 2018.

(4) The approval periods of the active substances clopyralid, cyprodinil, fosetyl, pyrimethanil and trinexapac were extended by Commission Implementing Regulation (EU) No 678/2014. The approval periods of those substances will expire on 30 April 2018.

(5) The approval periods of the active substances dichlorprop-P, metconazole and triclopyr were extended by Commission Implementing Regulation (EU) No 878/2014. The approval periods of those substances will expire on 30 April 2018.

(6) Applications for the renewal of the approval of the substances referred to in recitals 2 to 5 were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.

(7) Due to the fact that the assessment of the substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.

(8) In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

(9) Taking into account that the approvals of the active substances expire on 30 April 2018, this Regulation should enter into force as soon as possible.

(10) Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(11) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 28 March 2018. For the Commission The President Jean-Claude Juncker

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1) in the sixth column, expiration of approval, of row 73, Thiram, the date is replaced by 30 April 2019;

(2) in the sixth column, expiration of approval, of row 74, Ziram, the date is replaced by 30 April 2019;

(3) in the sixth column, expiration of approval, of row 82, Quinoxyfen, the date is replaced by 30 April 2019;

(4) in the sixth column, expiration of approval, of row 89, Pseudomonas chlororaphis Strain: MA 342, the date is replaced by 30 April 2019;

(5) in the sixth column, expiration of approval, of row 90, Mepanipyrim, the date is replaced by 30 April 2019;

(6) in the sixth column, expiration of approval, of row 92, Thiacloprid, the date is replaced by 30 April 2019;

(7) in the sixth column, expiration of approval, of row 123, Clodinafop, the date is replaced by 30 April 2019;

(8) in the sixth column, expiration of approval, of row 124, Pirimicarb, the date is replaced by 30 April 2019;

(9) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by 30 April 2019;

(10) in the sixth column, expiration of approval, of row 126, Tolclofos-methyl, the date is replaced by 30 April 2019;

(11) in the sixth column, expiration of approval, of row 127, Triticonazole, the date is replaced by 30 April 2019;

(12) in the sixth column, expiration of approval, of row 129, Clopyralid, the date is replaced by 30 April 2019;

(13) in the sixth column, expiration of approval, of row 130, Cyprodinil, the date is replaced by 30 April 2019;

(14) in the sixth column, expiration of approval, of row 131, Fosetyl, the date is replaced by 30 April 2019;

(15) in the sixth column, expiration of approval, of row 132, Trinexapac, the date is replaced by 30 April 2019;

(16) in the sixth column, expiration of approval, of row 133, Dichlorprop-P, the date is replaced by 30 April 2019;

(17) in the sixth column, expiration of approval, of row 134, Metconazole, the date is replaced by 30 April 2019;

(18) in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by 30 April 2019;

(19) in the sixth column, expiration of approval, of row 136, Triclopyr, the date is replaced by 30 April 2019;

(20) in the sixth column, expiration of approval, of row 137, Metrafenone, the date is replaced by 30 April 2019;

(21) in the sixth column, expiration of approval, of row 138, Bacillus subtilis (Cohn 1872) Strain QST 713, identical with strain AQ 713, the date is replaced by 30 April 2019;

(22) in the sixth column, expiration of approval, of row 139, Spinosad, the date is replaced by 30 April 2019;

(23) in the sixth column, expiration of approval, of row 140, Thiamethoxam, the date is replaced by 30 April 2019.

Versions

  1. 2018-03-28

Cited by